Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation

American Journal of Cardiovascular Drugs

Volumn 11, Issue 4, 2011, Pages 277-284

  El Haddad, Mohamed A ^a,b   Zalawadiya, Sandip K ^b   Awdallah, Hany ^a   Sabet, Sameh ^a   El Haddad, Haitham A ^c   Mostafa, Ashraf ^b   Rashed, Ahmed ^c   El Naggar, Wael ^c   Farag, Nabil ^a   Saleb, Mohamed A ^a   Jacob, Sony ^b  

^a Dar Al Fouad Hospital   (Egypt)

^b WAYNE STATE UNIVERSITY   (United States)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Atrial fibrillation; Coronary artery bypass graft surgery; Irbesartan

Indexed keywords

IRBESARTAN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART PROTECTION; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINGLE BLIND PROCEDURE;

AGE FACTORS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ATRIAL FIBRILLATION; BIPHENYL COMPOUNDS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TETRAZOLES;

EID: 79960250577     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/11587160-000000000-00000     Document Type: Article

References (42)

1. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997; 336: 1429-34 (Pubitemid 27208603)
2. Asher CR, Miller DP, Grimm RA, et al. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol 1998; 82: 892-5 (Pubitemid 28467365)
3. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56: 539-49 (Pubitemid 23294415)
4. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol 2004; 43: 742-8 (Pubitemid 38296469)
5. Carnes CA, Chung MK, Nakayama T, et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001; 89: E32-8
6. Gaudino M, Andreotti F, Zamparelli R, et al. The 174G/C interleukin-6 levels and postoperative atrial fibrillation: is atrial fibrillation an inflammatory complication? Circulation 2001; 108: II195-9 (Pubitemid 37099954)
7. Dupont E, Ko Y, Rothery S, et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 2001; 103: 842-9 (Pubitemid 32163883)
8. Leung JM, Bellows WH, Schiller NB. Impairment of left atrial function predicts post-operative atrial fibrillation after coronary artery bypass graft surgery. Eur Heart J 2004; 25: 1836-44 (Pubitemid 39330235)
9. Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000; 101: 2678-81
10. Oosterga M, Voors AA, Pinto YM, et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study [QUinapril on Vascular Ace and Determinants of ISchemia]. Am J Cardiol 2001; 87: 542-6 (Pubitemid 32178447)
11. Weightman WM, Newman MA. Drug therapy before coronary artery operations. J Thorac Cardiovasc Surg 1999; 118: 979-80 (Pubitemid 29511095)
12. Pan W, Pintar T, Anton J, et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004; 110: II45-9 (Pubitemid 39263697)
13. Forlani S, Moscarelli M, Scafuri A, et al. Combination therapy for prevention of atrial fibrillation after coronary artery bypass surgery: a randomized trial of sotalol and magnesium. Card Electrophysiol Rev 2003; 7: 168-71 (Pubitemid 37540801)
14. Ferguson Jr TB, Coombs LP, Peterson ED. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002; 287: 2221-7 (Pubitemid 34441938)
15. Aasbo JD, Lawrence AT, Krishnan K, et al. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann Intern Med 2005; 143: 327-36
16. White CM, Kluger J, Lertsburapa K, et al. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg 2007; 31: 817-20
17. Coleman CI, Makanji S, Kluger J, et al. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of postcardiothoracic surgery atrial fibrillation. Ann Pharmacother 2007; 41: 433-7 (Pubitemid 46536034)
18. Ozaydin M, Dede O, Varol E, et al. Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation. Int J Cardiol 2008; 127: 362-7 (Pubitemid 351885086)
19. Carrel T, Englberger L,Mohacsi P, et al. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg 2000; 15: 347-53 (Pubitemid 32977031)
20. Arora P, Rajagopalam S, Ranjan R, et al. Preoperative use of angiotensinconverting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3: 1266-73
21. Anand K, Mooss AN, Hee TT, et al. Meta-analysis: inhibition of reninangiotensin system prevents new-onset atrial fibrillation. Am Heart J 2006; 152: 217-22 (Pubitemid 44093401)
22. Pedersen OD, Bagger H, Kober L, et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation 1999; 100: 376-80 (Pubitemid 29362407)
23. LAllier PL, Ducharme A, Keller PF, et al. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. J Am Coll Cardiol 2004; 44: 159-64 (Pubitemid 38976480)
24. Vermes E, Tardif JC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003; 107: 2926-31 (Pubitemid 36736634)
25. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-9 (Pubitemid 38489894)
26. Cooper WA, OBrien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113: 1063-70
27. Iravanian S, Dudley Jr SC. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm 2008; 5: S12-7
28. Makkar KM, Sanoski CA, Spinler SA. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Pharmacotherapy 2009; 29: 31-48
29. Larochelle P, Flack JM, Marbury TC, et al. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators. Am J Cardiol 1997; 80: 1613-5 (Pubitemid 28011845)
30. Zaman AG, Archbold RA, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: amodel for preoperative risk stratification. Circulation 2000; 101: 1403-8 (Pubitemid 30169862)
31. Davies MJ, Pomerance A. Pathology of atrial fibrillation in man. Br Heart J 1972; 34: 520-5
32. Connolly SJ, Cybulsky I, Lamy A, et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study. Am Heart J 2003; 145: 226-32 (Pubitemid 36207942)
33. Ishii Y, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation 2005; 111: 2881-8 (Pubitemid 40814180)
34. Boyle Jr EM, Pohlman TH, Johnson MC, et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 1997; 63: 277-84 (Pubitemid 27039090)
35. Schnabel RB, Larson MG, Yamamoto JF, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010; 121: 200-7
36. Del Fiorentino A, Cianchetti S, Celi A, et al. The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man. Vasc Health Risk Manag 2009; 5: 233-42
37. Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98: 121-8 (Pubitemid 43902687)
38. Bristow MR, Abraham WT. Anti-adrenergic effects of angiotensin converting enzyme inhibitors. Eur Heart J 1995; 16 Suppl. K: 37-41 (Pubitemid 26031512)
39. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997; 96: 1686-95 (Pubitemid 27375370)
40. Verheule S, Wilson E, Banthia S, et al. Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation. Am J Physiol Heart Circ Physiol 2004; 287: H634-44 (Pubitemid 38955294)
41. Kumagai K, Nakashima H, Urata H, et al. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003; 41: 2197-204 (Pubitemid 36724267)
42. Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002; 106: 331-6 (Pubitemid 34778957)